FDA Adverse Event Malfunction Summary report: N

ACTIVA

MDR report key: 5359774 · Received January 12, 2016

Report

Report Number
3004209178-2016-00372
Event Type
Malfunction
Date Received
January 12, 2016
Report Date
October 1, 2015
Manufacturer
MEDTRONIC PUERTO RICO OPERATIONS CO.
Product Code
MHY
PMA / PMN Number
P960009
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

CONCOMITANT MEDICAL PRODUCTS: PRODUCT ID: 3389-40, LOT# V641328, IMPLANTED: (B)(6) 2012, PRODUCT TYPE: LEAD. PRODUCT ID: 3389S-40, LOT# V853915, IMPLANTED: (B)(6) 2012, PRODUCT TYPE: LEAD. (B)(4).

Description of Event or Problem · 1

ADDITIONAL INFORMATION RECEIVED FROM THE MANUFACTURER REPRESENTATIVE (REP) REPORTED THAT THE PATIENT EXPERIENCED INCREASED SIDE EFFECTS WITH TINGLING AND DYSKINESIAS. HE NEEDED TO TURN HIS SYSTEM DOWN FROM THE PREVIOUS SETTINGS. IMPEDANCE CHECKS WERE DONE IN CLINIC TO TROUBLESHOOT. NO ACTIONS OR INTERVENTIONS WERE TAKEN TO RESOLVE THE HIGH IMPEDANCES AND THE CAUSE WAS NOT DETERMINED.

Description of Event or Problem · 1

A MANUFACTURING REPRESENTATIVE REPORTED THAT A PATIENT WHOSE INDICATION FOR USE IS PARKINSON'S DUAL AND MOVEMENT DISORDERS HAD IMPEDANCE WITH PRIMARY CELL DEVICE FROM (B)(6) 2014 WHICH WERE AS FOLLOWS: C/8 AROUND 1456, C/9-4200, C/10-4077, C/11-3163, 8/9-4798, 8/10 - IN 4000S, 8/11- IN 4000S, 9/10-8971, 9/11-7500, 10/11-7300, C/0-1485, C/1-1457, C/2-2724, C/3-2469, 0/1-2001, 0/2-3680, 0/3-3534, 1/2-3416, 1/3-3416 AND 2/3-4486. FURTHER FOLLOW-UP IS BEING CONDUCTED TO OBTAIN INFORMATION ABOUT SYMPTOMS, TROUBLESHOOTING, ACTIONS/INTERVENTIONS TAKEN AND CAUSE. IF ADDITIONAL INFORMATION IS RECEIVED A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
20926 ACTIVA STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR MHY MEDTRONIC PUERTO RICO OPERATIONS CO. 37601

Patients

Seq Age Sex Outcome Treatment
1 00047 YR